Last reviewed · How we verify

NCT06237985

Effect of Conservative Root Canal Instrumentation on the Release of Inflammatory Mediators in Root Canal Treatments

Status unknown NA Last updated 2 February 2024
What this trial tests

NA trial testing ProTaper Gold file system in Irreversible Pulpitis in 60 participants. Status unknown.

Timeline
15 February 2024
Primary endpoint
15 April 2024
30 April 2024

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date15 February 2024
Primary completion15 April 2024
Estimated completion30 April 2024

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 18 to 60, any sex, with Irreversible Pulpitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the expression of inflammatory mediators in the crevicular fluid and periodontal ligament after one-visit root canal treatment of mandibular molars of patients with asymptomatic irreversible pulpitis using 3 different file systems. The main question it aims to answer is: Does conservative root canal preparation cause decreased expression of inflammatory mediators compared to conventional root canal preparation? In this context, patients will be divided into 3 groups based on the file systems as follows: ProTaper Gold, OneShape, and TruNatomy up to apical size #25. Both inflammatory mediator expression and postoperative VAS values will be compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Irreversible Pulpitis

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06237985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing